The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Inhibition of gamma-secretase activity in combination with paclitaxel to reduce platinum-resistant ovarian tumor growth.
Jolijn W Groeneweg
No relevant relationships to disclose
Celeste M DiGloria
No relevant relationships to disclose
Whitfield Board Growdon
No relevant relationships to disclose
Sriram Sathyanarayanan
Employment or Leadership Position - Merck
Stock Ownership - Merck
Rosemary Foster
No relevant relationships to disclose
Bo R Rueda
No relevant relationships to disclose